ArticleClinical rheumatology2026
Ischemic stroke in eosinophilic granulomatosis with polyangiitis: a single-center retrospective cohort study.
Article in Clinical rheumatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo examine the associations between clinical characteristics and the occurrence of ischemic stroke (IS), and to describe the clinical features and outcomes of IS in patients with eosinophilic granulomatosis with polyangiitis (EGPA).
methodsIn this single-center retrospective cohort study, 38 EGPA patients were stratified by ischemic stroke occurrence. Analyses included logistic regression and Kaplan-Meier survival analysis.
resultsIS occurred in 8 patients (21.1%). The IS group had significantly higher rates of cardiac involvement (62.5% vs 20.0%, p = 0.031), active disease (BVAS ≥ 15: 87.5% vs 43.3%, p = 0.045), and Five-Factor Scores (p = 0.004). Strokes were predominantly bilateral (62.5%) and multifocal (75.0%). Cardiac involvement had a strong association with an increased risk (odds ratio = 15.0, 95% CI 2.3-97.0). Most patients (62.5%) achieved complete remission and functional independence after treatment.
conclusionCardiac involvement is significantly associated with an increased risk of IS in EGPA, which presents with distinct bilateral/multifocal imaging patterns. Prompt immunosuppressive therapy is effective, but stroke recurrence remains a concern, underscoring the need for systematic cardiac screening and sustained long-term management.
Indexed as
Identifiers
41942624What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.